149 related articles for article (PubMed ID: 19458629)
1. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells.
Carter BZ; Mak DH; Woessner R; Gross S; Schober WD; Estrov Z; Kantarjian H; Andreeff M
Leukemia; 2009 Oct; 23(10):1755-62. PubMed ID: 19458629
[TBL] [Abstract][Full Text] [Related]
2. Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520.
Tunquist BJ; Woessner RD; Walker DH
Mol Cancer Ther; 2010 Jul; 9(7):2046-56. PubMed ID: 20571074
[TBL] [Abstract][Full Text] [Related]
3. KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL.
Zhu L; Xiao F; Yu Y; Wang H; Fang M; Yang Y; Sun H; Wang L; Sheng Y
Anticancer Drugs; 2016 Oct; 27(9):863-72. PubMed ID: 27379929
[TBL] [Abstract][Full Text] [Related]
4. ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.
Woessner R; Tunquist B; Lemieux C; Chlipala E; Jackinsky S; Dewolf W; Voegtli W; Cox A; Rana S; Lee P; Walker D
Anticancer Res; 2009 Nov; 29(11):4373-80. PubMed ID: 20032381
[TBL] [Abstract][Full Text] [Related]
5. Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells.
Yin Y; Sun H; Xu J; Xiao F; Wang H; Yang Y; Ren H; Wu CT; Gao C; Wang L
Leuk Lymphoma; 2015 Jun; 56(6):1813-20. PubMed ID: 25146433
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis.
Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB
Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792
[TBL] [Abstract][Full Text] [Related]
7. KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells.
Kim KH; Xie Y; Tytler EM; Woessner R; Mor G; Alvero AB
J Transl Med; 2009 Jul; 7():63. PubMed ID: 19619321
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways.
Vijapurkar U; Wang W; Herbst R
Cancer Res; 2007 Jan; 67(1):237-45. PubMed ID: 17210704
[TBL] [Abstract][Full Text] [Related]
9. The induction of G2/M cell-cycle arrest and apoptosis by cucurbitacin E is associated with increased phosphorylation of eIF2alpha in leukemia cells.
Li Y; Wang R; Ma E; Deng Y; Wang X; Xiao J; Jing Y
Anticancer Drugs; 2010 Apr; 21(4):389-400. PubMed ID: 20110807
[TBL] [Abstract][Full Text] [Related]
10. p70S6 kinase is a target of the novel proteasome inhibitor 3,3'-diamino-4'-methoxyflavone during apoptosis in human myeloid tumor cells.
Piedfer M; Bouchet S; Tang R; Billard C; Dauzonne D; Bauvois B
Biochim Biophys Acta; 2013 Jun; 1833(6):1316-28. PubMed ID: 23481040
[TBL] [Abstract][Full Text] [Related]
11. MSFTZ, a flavanone derivative, induces human hepatoma cell apoptosis via a reactive oxygen species- and caspase-dependent mitochondrial pathway.
Ying M; Tu C; Ying H; Hu Y; He Q; Yang B
J Pharmacol Exp Ther; 2008 Jun; 325(3):758-65. PubMed ID: 18323457
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.
Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB
Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598
[TBL] [Abstract][Full Text] [Related]
14. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.
Carter BZ; Mak DH; Schober WD; Koller E; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2010 Jan; 115(2):306-14. PubMed ID: 19897582
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane-induced apoptosis in human leukemia HL-60 cells through extrinsic and intrinsic signal pathways and altering associated genes expression assayed by cDNA microarray.
Shang HS; Shih YL; Lee CH; Hsueh SC; Liu JY; Liao NC; Chen YL; Huang YP; Lu HF; Chung JG
Environ Toxicol; 2017 Jan; 32(1):311-328. PubMed ID: 26833863
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors.
Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA
Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746
[TBL] [Abstract][Full Text] [Related]
18. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
Yacoub A; Mitchell C; Hong Y; Gopalkrishnan RV; Su ZZ; Gupta P; Sauane M; Lebedeva IV; Curiel DT; Mahasreshti PJ; Rosenfeld MR; Broaddus WC; James CD; Grant S; Fisher PB; Dent P
Cancer Biol Ther; 2004 Aug; 3(8):739-51. PubMed ID: 15197348
[TBL] [Abstract][Full Text] [Related]
19. Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Jacque N; Ronchetti AM; Larrue C; Meunier G; Birsen R; Willems L; Saland E; Decroocq J; Maciel TT; Lambert M; Poulain L; Hospital MA; Sujobert P; Joseph L; Chapuis N; Lacombe C; Moura IC; Demo S; Sarry JE; Recher C; Mayeux P; Tamburini J; Bouscary D
Blood; 2015 Sep; 126(11):1346-56. PubMed ID: 26186940
[TBL] [Abstract][Full Text] [Related]
20. A phase 1 dose-escalation study of ARRY-520, a kinesin spindle protein inhibitor, in patients with advanced myeloid leukemias.
Khoury HJ; Garcia-Manero G; Borthakur G; Kadia T; Foudray MC; Arellano M; Langston A; Bethelmie-Bryan B; Rush S; Litwiler K; Karan S; Simmons H; Marcus AI; Ptaszynski M; Kantarjian H
Cancer; 2012 Jul; 118(14):3556-64. PubMed ID: 22139909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
